Real-time enrollment status for this temporal lobe epilepsy clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:47 AM UTC
| NCT Number | NCT06063850 |
| Recruiting Status | Recruiting |
| Condition | Temporal Lobe Epilepsy |
| Phase | Clinical Trial |
| Target Enrollment | 12 participants |
| Active Locations | 18 sites in the US |
| Sponsor | UniQure Biopharma B.V. |
| Last Updated on CT.gov | December 10, 2025 (Dec 10, 2025) |
As of March 2, 2026: Clinical trial NCT06063850 is currently recruiting participants. This clinical trial study for temporal lobe epilepsy is actively seeking new participants at 18 locations across the United States. The study is sponsored by UniQure Biopharma B.V.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06063850 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06063850 was last updated Dec 10, 2025 (December 10, 2025). HelloStudys verifies this status automatically.